NANOFORCE- Nanotechnology for Chemical Enterprises – how to link scientific knowledge to the business in the Central Europe

Sonja Hartl 

BioNanoNet Research Association, Elisabethstraße 9-11, Graz 8010, Austria


Introduction:The 30 months long NANOFORCE project, which is performed in 8 regions of Central Europe belonging to 7 Countries, is developed by national & regional chemistry associations and R&D Centers of the Central Europe area. As result of the gradually increasing nanotechnology sector there is the necessity of a larger international cooperation and research’s coordination to overcome disciplinary boundaries, to fill the gap between more and less experienced regions and to turn investments in R&D in industrial innovations.

One of the main objectives of NANOFORCE project is to improve the environmental, health and safety knowledge and develop a state-of-the-art report on regulations in the field of nanotechnology to identify needs and gaps and give possible recommendations for the European Commission. Therefore the first actions of the NANOFORCE project was the development of questionnaires for producers, downstream users, researchers and financiers with the goal to collect information about the nanotechnology sector in the Central Europe region concerning development, financial status, international cooperation within joint ventures, safety and nanotoxicology. The results achieved are presented in regional related reports on nanotechnology business as well as a state of the art report on existing safety procedures and nanotech related legislation.

The BioNanoNet Forschungsgesellschaft mbH is an Austrian network which combines a wide range of expertise in numerous disciplines of medical and pharmaceutical research in nanomedicine and nanotoxicology and acts as work package leader in the NANOFORCE project. Additionally the BioNanoNet functions as coordinator of the European Center for Nanotoxicology (EURO-NanoTox), an Austrian example of a European hub in nanotoxicology. Within the aim of EURO-NanoTox, the BioNanoNet offers regulatory expertise, dissemination and communication service, scientific reviewing of testing methods and a panel of standardized in vitro and in vivo toxicity tests, with the overall goal of driving innovative interdisciplinary research.

Focus: The general objective of NANOFORCE is to foster the innovative nanotechnology-sector networks across Central Europe regions by bringing together public and private organizations (enterprises, research centers, venture capitalists and public institutions) to carry out collaborative and interdisciplinary researches on nanomaterials (in the frame of REACH Regulation) and to turn the most promising laboratory results into innovative industrial applications.

Within this contribution the main objectives of the NANOFORCE project will be presented as well as first results. Furthermore the BioNanoNet will present its work and the EURO-NanoTox as well as the ONLINE-Journal “EURO-NanoTox-Letters”.


Auxiliary resources (full texts, presentations, posters, etc.)
  1. PRESENTATION: NANOFORCE- Nanotechnology for Chemical Enterprises - how to link scientific knowledge to the business in the Central Europe, PDF document, version 1.5, 1MB

Legal notice
  • Legal notice:

    Copyright (c) Pielaszek Research, all rights reserved.
    The above materials, including auxiliary resources, are subject to Publisher's copyright and the Author(s) intellectual rights. Without limiting Author(s) rights under respective Copyright Transfer Agreement, no part of the above documents may be reproduced without the express written permission of Pielaszek Research, the Publisher. Express permission from the Author(s) is required to use the above materials for academic purposes, such as lectures or scientific presentations.
    In every case, proper references including Author(s) name(s) and URL of this webpage: must be provided.


Presentation: Invited oral at Nano-Biotechnologia PL, by Sonja Hartl
See On-line Journal of Nano-Biotechnologia PL

Submitted: 2012-07-05 09:08
Revised:   2012-07-05 09:09